Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Non-Current Debt (2021 - 2025)

Cannabist Co Holdings (CBSTF) has disclosed Non-Current Debt for 5 consecutive years, with $298.7 million as the latest value for Q3 2025.

  • Quarterly Non-Current Debt rose 20.15% to $298.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $298.7 million through Sep 2025, up 20.15% year-over-year, with the annual reading at $249.5 million for FY2024, 16.12% down from the prior year.
  • Non-Current Debt hit $298.7 million in Q3 2025 for Cannabist Co Holdings, roughly flat from $297.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $323.1 million in Q1 2023 to a low of $159.0 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $277.7 million across 5 years, with a median of $289.8 million in 2022.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 77.15% in 2022 and later fell 18.44% in 2025.
  • Year by year, Non-Current Debt stood at $159.0 million in 2021, then surged by 77.15% to $281.7 million in 2022, then increased by 5.6% to $297.5 million in 2023, then decreased by 16.12% to $249.5 million in 2024, then grew by 19.7% to $298.7 million in 2025.
  • Business Quant data shows Non-Current Debt for CBSTF at $298.7 million in Q3 2025, $297.7 million in Q2 2025, and $248.5 million in Q1 2025.